PPD, Inc. has opened a vaccine clinical research center in China Medical City located in Taizhou. PPD will use to center to provide clinical monitoring services for multinational and local companies that are seeking approval for new vaccines in China. The new facility adds to PPD’s presence in China. In November of last year, PPD bought two China-based CROs, Excel PharmaStudies and BioDuro LLC, which began the major consolidation of CROs in China. More details...

Stock Symbol: (NSDQ: PPDI)